Polysil Irrigati (POLYSIL)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹164.9 |
| Market Cap | ₹468.11 Cr |
| P/E Ratio | 0 |
| ROCE | 1.24% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 2.88% |
| Debt/Equity | — |
| Sales Growth | 76.06% |
| Promoter Holding | 28.02% |
| 52-Week Range | ₹49.7 — ₹356.75 |
| Sector | Industrial Products |
Strengths
- Sales growth of 76.06% shows strong top-line expansion.
- Piotroski F-Score of 7/9 suggests several financial health metrics are improving.
- Latest quarter is net profitable: ₹1 Cr profit on ₹15 Cr sales.
Concerns
- P/E reported as 0.00 means there is no meaningful earnings stream to support the valuation.
- ROCE of just 1.24% indicates very poor return on capital employed.
- Profit growth of 2.88% is far behind sales growth of 76.06%, showing weak conversion to earnings.
- Book value, ROE and debt/equity are all N/A, making the balance sheet impossible to assess.
AI Analysis
Let me begin with what I value most: the return on capital. ROCE stands at 1.24%, so for every ₹100 the company employs, it earns roughly ₹1.24 before capital costs. That is not a business; that is a capital trap. The P/E is reported as 0.00, which in my language means there is no meaningful earnings power I can hang my hat on. Sales grew 76.06%, but profit growth was only 2.88%; the latest quarter shows ₹15 Cr of sales yielding ₹1 Cr of net profit. Even that margin is thin for a plastic-products industrial company. The market price of ₹164.90 gives a market cap of ₹468 Cr; annualising the quarter gives ₹60 Cr sales, so the market is paying close to 8 times sales for a company with almost no return on capital. That is far too generous. The absence of book value, ROE and debt/equity data is itself a warning: I can't assess the balance sheet, and I never invest in what I cannot measure. Promoter holding is 28.02%—not the kind of owner-operator commitment I like to see. Dividend yield is zero, so there is no cash return while I wait. The only positives are the 76% sales growth and a Piotroski F-score of 7/9, which hints that some financial health indicators are improving. But sales growth without profit growth is just expensive effort. The 52-week range of ₹70.95 to ₹356.75 reminds me that Mr. Market has been manic. This is a possible turnaround, but I need proof of durable profitability and better capital efficiency before I will part with my money. I'll watch from the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer